Explore Business Standard
GlaxoSmithKline Pharmaceuticals on Thursday said its board has approved a Voluntary Retirement Scheme (VRS) for a certain segment of employees under a strategic review of the business. In a regulatory filing, the drug firm said its board has approved a commercial transformation initiative as part of a strategic review of the business. "As part of the transformation and to continue to remain competitive, the company will explore new innovative solutions, including omnichannel strategy, to expand its reach and coverage to the target segments," the drug firm said. Further, the company has launched a voluntary retirement scheme for commercial function employees in field sales and head office. The initiative includes provisions for financial and transition support. The financial impact will be communicated separately, GlaxoSmithKline Pharmaceuticals said.
Air India has given an option to the cabin crew who have opted for voluntary retirement scheme to extend their tenure until January 31 next year, amid shortage of cabin crew and long waiting period for US visas, according to sources. The Tata group-owned airline, which is being revived with expanding fleet and routes, offered Voluntary Retirement Scheme (VRS) to its employees, including the cabin crew, in June this year. The relieving date for those who opted for the VRS was fixed as November 30. The sources said around 4,500 employees had applied for the scheme. "The release date from the services of the company for VRS crew has been extended. Crew members may choose to extend their release date till January 31, 2023," the airline said in a communication on Saturday. A query sent to Air India seeking comments on the matter remained unanswered. According to the communication, the VRS scheme remains unchanged and the VRS benefit will be applicable to employees who are extending the